Capsida Biotherapeutics
Christopher Octeau is a Principal Scientist at Capsida Biotherapeutics, bringing with him a strong background in research and academia. Previously, Christopher worked as a Postdoctoral Scholar at the David Geffen School of Medicine at UCLA and as a Graduate Research Assistant at the University of Rhode Island. Christopher also has experience as an Undergraduate Research Assistant at Boston University. With a Ph.D. in Pharmaceutical Sciences, Christopher has a passion for scientific exploration and discovery.
This person is not in any offices
Capsida Biotherapeutics
1 followers
Capsida is a biotechnology company that specializes in tackling monogenetic and sporadic CNS and non-CNS disorders.